Cocrystal Pharma (COCP) Return on Capital Employed Growth (5y) (2016 - 2026)
Cocrystal Pharma (COCP) Return on Capital Employed Growth (5y) (2016 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Cocrystal Pharma | 12.57 Mn | 7.74 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12,279.00 |
| Dec 31, 2025 | -9,631.00 |
| Sep 30, 2025 | 392.00 |
| Jun 30, 2025 | -2,169.00 |
| Mar 31, 2025 | -90.00 |
| Dec 31, 2024 | -4,459.00 |
| Sep 30, 2024 | -3,512.00 |
| Jun 30, 2024 | -960.00 |
| Mar 31, 2024 | 1,566.00 |
| Dec 31, 2023 | 164.00 |
| Sep 30, 2023 | -4,975.00 |
| Jun 30, 2023 | -4,874.00 |
| Mar 31, 2023 | -10,300.00 |
| Dec 31, 2022 | -8,477.00 |
| Sep 30, 2022 | 346.00 |
| Jun 30, 2022 | 2,403.00 |
| Mar 31, 2022 | 6,446.00 |
| Dec 31, 2021 | 4,404.00 |
| Jun 30, 2018 | -14,351.00 |
| Mar 31, 2018 | -14,927.00 |